Furthermore, increased NEIL2 expression enhances the sensitivity of breast cancer cells to double-strand breaks and apolipoprotein B mRNA editing enzyme catalytic subunit 3 (APOBEC3) deaminase-mediated mutations by interfering with BER (Shen et al., 2020). The gene discussed is NEIL2; the disease is breast carcinoma.